From ANIMAL PEOPLE, April 2004:
FAYETTE, Missouri; BANGKOK–If humane organizations could
afford to use Neutersol in high volume, it might have taken over
much of the male dog sterilization market share already, worldwide.
But the maker of the first commercially distributed injectible
sterilant for dogs, Addison Laboratories of Fayette, Missouri, has
priced Neutersol to avoid cutting into U.S. veterinary profits.
Because Neutersol is unaffordable in the economically disadvantaged
nations where roving street dogs are most a problem, foreign
competitors are rushing to perfect their own injectible sterilants
and grab market share before Addison can introduce a two-tier pricing
system that would make Neutersol the injectible sterilant of choice.
At request of Neutersol product director Cord Harper, ANIMAL
PEOPLE on November 17, 2003 e-mailed to Addison Laboratories a list
of 37 humane organizations in 20 nations that might be willing to use
Neutersol if it could be provided to them at cost. At least five of
the organizations have already experimented with injectible
sterilants and still favor the concept, despite some early product
Four months later, Neutersol is still not affordably
available to help control street dogs.
Internationally recognized rabies control expert Henry Wilde,
M.D., of the Queen Savabha Memorial Institute operated by the Thai
Red Cross in Bangkok, was enthusiastic enough about the potential of
Neutersol that he bought some at the regular U.S. price and tested it
on several adult dogs in anticipation of two-tier pricing. Then he